Cabot Corporation

NYSE:CBT

Chemicals - Specialty

Basic Materials
$74.03 +1.09%

+$0.96 today

Market cap
$3.80B
Beta
0.83
P/E (TTM)
16.3
EPS (TTM)
$5.48
Dividend yield
2.04%
52W Low $58.33High $90.08

Volume 0.53M

Average 0.43M

CBT Inventory

Cash effect of the change in inventory; building inventory consumes cash.

Cabot CorporationNYSE: CBT

Inventory · Q3 FY2026 · quarter ended Jun 2026

Inventory turns negative

Q3 FY2026 inventory was -$46M, compared with $27M a year earlier. Trailing-twelve-month inventory was -$18M.

Context

  • Inventory amounted to 1.3% of revenue in FY2025, up 0.2 pp from a year earlier.
  • Inventory increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly inventory holds near -$46M or moves back toward the trailing-twelve-month quarterly average of -$4.5M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$46M+2200.0% QoQ
Last fiscal yearSep 2025
$47M+14.6% YoY
LTMJun 2026
-$18M-154.5% YoY
Inventory past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-270.4%——
1 year+14.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Inventory history

USD · from the cash flow

Latest · FY2025
47M USD
Year-over-year change
+14.6%

Inventory vs competitors

How CBT compares with its peers on the latest reported figures

  • Peers report in different currencies, so inventory is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -154.5% is the lowest of 10, against a peer median of +88.0%.
  • Inventory amounts to 0.5% of revenue for CBT, versus a peer median of 0.6%.
CBT Competitors
Inventory for CBT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SSLSasol LimitedFY2026ZAR 11.2B ZAR+2350.3%—4.2%
SXTSensient Technologies CorporationLTM Jun 2026$104.49M USD+88.0%-26.9%6.1%
FULH.B. Fuller CompanyLTM Aug 2026$74.66M USD+647.5%-43.0%2.1%
CECelanese CorporationLTM Jun 2026$64M USD-123.8%—0.7%
AVNTAvient CorporationLTM Sep 2026$54.5M USD+512.4%-65.0%1.6%
KNFKnife River CorporationLTM Jun 2026$19.78M USD-49.0%-24.3%0.6%
CBTCabot CorporationLTM Jun 2026$18M USD-154.5%—0.5%
WDFCWD-40 CompanyLTM Aug 2026$1.52M USD-33.9%—0.2%
PRMPerimeter Solutions, Inc.LTM Jun 2026$704.53K USD-86.9%-54.1%0.1%
HWKNHawkins, Inc.LTM Sep 2026$699K USD+113.0%+28.7%0.1%
MEOHMethanex CorporationLTM Jun 2026$0 USD——0.0%
Peer median (excluding CBT) —+88.0%-34.9%0.6%

Competitors are the stored peer set for CBT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Net Income286M243M484M424M376M
Depreciation & Amortization160M146M144M151M154M
Deferred Income Tax9M(40M)(156M)(37M)32M
Stock-Based Compensation21M23M20M25M24M
Change in Working Capital(244M)(448M)100M70M49M
Accounts Receivables7M(287M)153M(26M)76M
Inventory(174M)(259M)96M41M47M
Accounts Payables167M115M(152M)42M(67M)
Other Working Capital(244M)(17M)3M13M(7M)
Other Non-Cash Items25M176M3M59M30M
Operating Cash Flow257M100M595M692M665M
Capital Expenditures(195M)(211M)(244M)(241M)(274M)
Acquisitions (Net)(92M)70M6M00
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities101M23M24M6M(24M)
Investing Cash Flow(186M)(118M)(214M)(235M)(298M)
Debt Repayment36M298M(179M)(143M)(23M)
Common Stock Issued6M6M4M20M8M
Common Stock Repurchased(3M)(53M)(98M)(172M)(168M)
Dividends Paid(80M)(84M)(88M)(93M)(96M)
Other Financing Activities(19M)(22M)(42M)(27M)(57M)
Financing Cash Flow(60M)145M(403M)(415M)(336M)
Effect of Forex Changes8M(91M)54M(57M)4M
Net Change in Cash19M36M32M(15M)35M
Free Cash Flow62M(111M)351M451M391M

Cabot Corporation

NYSE:CBT

Intrinsic Alpha fair value

Locked

Current Price

$74.03

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.